Phathom Pharmaceuticals (PHAT)
(Delayed Data from NSDQ)
$10.39 USD
+0.72 (7.45%)
Updated May 14, 2024 04:00 PM ET
After-Market: $10.37 -0.02 (-0.19%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/08/2024
Time: -- |
6/2024 | $-1.71 | 0.00% |
Earnings Summary
For their last quarter, Phathom Pharmaceuticals (PHAT) reported earnings of -$1.42 per share, beating the Zacks Consensus Estimate of $-1.43 per share. This reflects a positive earnings surprise of 0.70%. Look out for PHAT's next earnings release expected on August 08, 2024. For the next earning release, we expect the company to report earnings of -$1.71 per share, reflecting a year-over-year decrease of 103.57%.
Earnings History
Price & Consensus
Zacks News for PHAT
Zacks.com featured highlights include Phathom Pharmaceuticals, Universal Stainless & Alloy Products and Arlo Technologies
PHAT: What are Zacks experts saying now?
Zacks Private Portfolio Services